Contract 75A50120C00092
Phlow Corp. · Department Of Health And Human Services · September 26, 2023
Phlow Corp. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2023 for $255.41 million of work in pharmaceutical preparation manufacturing. Performance is in Richmond, VA. It was awarded under full and open competition. The contract has been modified 22 times since the base award It uses cost-plus contract pricing. The most recent modification was on July 2, 2026. If all options are exercised, the contract could reach $969.75 million.
Contract details
- PIID
- 75A50120C00092
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- R&D- Medical: Biomedical (Commercialized)
- Place of performance
- Richmond, VA
- First action
- September 26, 2023
- Latest action
- July 2, 2026
Description
THE PURPOSE OF THIS MODIFICATION IS TO THE EXTEND THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00022 FROM JULY 3, 2026 TO SEPTEMBER 3, 2026.
Modification timeline
-
July 2, 2026Mod P00036 · Definitize Change Order$696.67M
-
June 30, 2026Mod P00035 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE END DATE OF CLIN 0005 AT NO ADDITIONAL COST TO THE GOVERNMENT$696.67M
-
June 24, 2026Mod P00034 · Definitize Change OrderTHE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00020 FROM JUNE 25, 2026 TO AUGUST 25, 2026$696.67M
-
March 3, 2026Mod P00030 · Definitize Change OrderTHE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MARCH 3, 2026 TO MAY 3, 2026$696.67M
-
February 19, 2026Mod P00029 · Definitize Change OrderTHE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0025 FROM FEB 25, 2026 TO APRIL 25, 2026$696.67M
-
January 30, 2026Mod P00028 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS ACTION IS TO EXTEND CLIN 0008 AT NO ADDITIONAL COST TO THE GOVERNMENT$696.67M
-
January 26, 2026Mod P00027 · Exercise An OptionTHE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE$696.67M
-
January 26, 2026Mod P00026 · Change OrderTHE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE$696.67M
-
January 5, 2026Mod P00025 · Other Administrative ActionTHE PURPOSE OF MODIFICATION P00020 IS TO EXERCISE OPTION CLIN 0010 AND INCORPORATE CHANGES TO THE DESCRIPTION OF SERVICES FOR DOMESTIC PRODUCIBILITY OF ESSENTIAL MEDICINES.$616.39M
-
December 12, 2025Mod P00024 · Other Administrative ActionCOR CHANGE$616.39M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
| Eminent Services Corp | Department Of Health And Human Services | June 24, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00092?
Contract 75A50120C00092 is a federal contract awarded to Phlow Corp. by Department Of Health And Human Services on September 26, 2023 for $255.41 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 22 times since the base award.
Who won contract 75A50120C00092?
Phlow Corp. won contract 75A50120C00092 from Department Of Health And Human Services.
How much is contract 75A50120C00092 worth?
Contract 75A50120C00092 has obligated $255.41 million to date, with a total potential value of $969.75 million if all options are exercised.